(Q42147144)

17 October 2017

Kappa1- and kappa2-opioid receptors mediating presynaptic inhibition of dopamine and acetylcholine release in rat neostriatum (English)

1 reference

17 October 2017

0 references

0 references

A N Schoffelmeer

1

1 reference

17 October 2017

F Hogenboom

series ordinal

2

1 reference

17 October 2017

A H Mulder

series ordinal

3

1 reference

17 October 2017

language of work or name

English

0 references

publication date

1 October 1997

1 reference

British Journal of Pharmacology

17 October 2017

1 reference

17 October 2017

122

1 reference

17 October 2017

3

1 reference

17 October 2017

520-524

1 reference

Pharmacological profile of various κ-agonists at κ-, μ- and δ-opioid receptors mediating presynaptic inhibition of neurotransmitter release in the rat brain

17 October 2017

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701394

Cloning of a delta opioid receptor by functional expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701394

7 January 2021

Opioid receptor-mediated inhibition of dopamine and acetylcholine release from slices of rat nucleus accumbens, olfactory tubercle and frontal cortex

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701394

7 January 2021

The delta-opioid receptor: isolation of a cDNA by expression cloning and pharmacological characterization

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701394

7 January 2021

The striatal cholinergic interneuron: synaptic target of dopaminergic terminals?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701394

7 January 2021

Cloning and pharmacological characterization of a rat kappa opioid receptor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701394

7 January 2021

Psychotomimesis mediated by kappa opiate receptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701394

7 January 2021

Role of the spacer in conferring .kappa. opioid receptor selectivity to bivalent ligands related to norbinaltorphimine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701394

7 January 2021

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701394

1 reference

7 January 2021

Interaction of endogenous opioid peptides and other drugs with four kappa opioid binding sites in guinea pig brain

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701394

7 January 2021

Mu-, delta- and kappa-opioid receptor-mediated inhibition of neurotransmitter release and adenylate cyclase activity in rat brain slices: studies with fentanyl isothiocyanate

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701394

7 January 2021

Opposing tonically active endogenous opioid systems modulate the mesolimbic dopaminergic pathway

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701394

7 January 2021

Cloning and pharmacological characterization of a rat mu opioid receptor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701394

7 January 2021

An opiate-receptor gene family reunion.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701394

7 January 2021

Cloning and functional comparison of kappa and delta opioid receptors from mouse brain

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701394

7 January 2021

Characterization and visualization of rat and guinea pig brain kappa opioid receptors: evidence for kappa 1 and kappa 2 opioid receptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701394

7 January 2021

Identifiers

DOI

10.1038/SJ.BJP.0701394

1 reference

17 October 2017

1 reference

17 October 2017

PubMed publication ID

9351509

1 reference